0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Paper |  FREE
Jon S. Thompson, MD; B. Timothy Baxter, MD; John G. Allison, MD; et al.
Arch Surg. 2003;138(6):596-603. doi:10.1001/archsurg.138.6.596.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Cardiology
Editor's Note  | 
Angiotensin Receptor Neprilysin Inhibitor Use Urgency Festina Lente
Clyde W. Yancy, MD, MSc; Gregg C. Fonarow, MD
JAMA Cardiology
Viewpoint  | 
Angiotensin Neprilysin Inhibition for Patients With Heart Failure What If Sacubitril/Valsartan Were a Treatment For Cancer?
Milton Packer, MD
JAMA Internal Medicine
Evidence to Practice  | 
CardioMEMS HF for the Management of Heart Failure—Effectiveness and Value
Daniel A. Ollendorf, PhD; Alexander T. Sandhu, MD; Steven D. Pearson, MD, MSc
JAMA Oncology
Viewpoint  | 
Cardiovascular Monitoring With Trastuzumab Therapy How Frequent Is Too Frequent?
Alison M. Brann, BS; Melody A. Cobleigh, MD; Tochi M. Okwuosa, DO